029 - Serum COMP (Cartilage Oligomeric Matrix Protein) levels: possibility of usage as marker of progressive articular damage in “Early Rheumatoid Arthritis” patients

Autor(s): I. Fineschi, G. Morozzi, R. De Stefano, F. Nargi, M. Fabbroni, E. Frati, G. Pucci, M. Galeazzi

Issue: RIMeL - IJLaM, Vol. 5, N. 1, 2009 (MAF Servizi srl ed.)

Page(s): 29-37

Background. Recent studies advice that the serum concentration of cartilage oligomeric matrix protein (COMP) in patients suffering from rheumatoid arthritis (RA) is a marker of progression of cartilage destruction. Nevertheless, even though these evidences, is still limited the practical use of this biochemical marker to predict tissue destruction.
The aim of the work was to study the possible contribution of COMP in the valuation of the level of the progression of structural damage, estimated by contrast RMN, in patients with AR in the first year of disease.
Methods. 16 patients with RA were studied, according with ACR criteria of the 1988; the start of the disease was less than 6 months ago. Out of each patient, at the beginning and after 6 months, was established the age, the sex, and the disease duration from the start of the articular symptoms, and a clinic-biohumoral and instrumental evaluation was also effected and registered. Serum samples were collected twice to do the hematologic and serum routine, besides dose of COMP with commercial kit “COMP ELISA” (AnaMar Medical, Lund, Sweden).
Results. The patients studied were divided in two groups according to the presence/absence of early erosion. The 75% of the patients showed already erosive lesions at the RMN at the beginning of the disease. The basal serum level of COMP was higher in the group with early erosion. The correlation between the basal serum level of COMP and the RMN score about the bone erosions was significant statistically at the beginning and after 6 months. The correlation between the variations of serum levels of COMP was also significant statistically (Δ RMN erosions 6 months vs basal) (r = 0,63; p = 0,0079). There were not correlations between the variations of RMN erosive score and the variations of clinical-biohumural parameters of inflammation.

Article in PDF format

Back to current issue